Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041860 | SCV000065556 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | 5572+15G>A in Intron 27 of USH2A: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence and has been identified in 3.8% (142/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.wa shington.edu/EVS; dbSNP rs17026052). |
ARUP Laboratories, |
RCV001509713 | SCV001477665 | benign | not provided | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001509713 | SCV001716564 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001509713 | SCV001867156 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496666 | SCV002805246 | benign | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2021-09-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445124 | SCV004172121 | benign | Retinitis pigmentosa 39 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003445123 | SCV004172123 | benign | Usher syndrome type 2A | 2023-04-11 | criteria provided, single submitter | clinical testing |